TB-CRE Pharmacology Symposium
The TB-CRE is delighted to announce the first Pharmacology Symposium, in person in Sydney and live-streamed online. The TB-CRE will be presenting how information on drug susceptibility of Mycobacterium tuberculosis and drug concentrations can be used to optimize treatment outcome in TB patients.
Venue
Program
1.00-1.05pm Opening Jan-Willem Alffenaar
1.05-1.30pm What are PK studies and how do they work? - Andrew Burke
1.30-2.00pm What are breakpoints, critical concentrations and ECOFFS and how do they relate to the drug dose? - Chris Coulter
2.00-2.30pm In vitro PK/PD and implications for clinical care - Shashikant Shrivasta
2.30-2.50pm BREAK
2.50-3.20pm What is micro sampling and how may it help TB studies and TDM? - Prakruti Rao
3.20-3.50pm Optimization of TB treatment in children, the role of PK - Tony Lai
3.50-4.00pm What next? - Jan-Willem Alffenaar
4.00-4.05pm Closing Andrew Burke